AR030957A1 - Composiciones de analgesico y glucosamina - Google Patents

Composiciones de analgesico y glucosamina

Info

Publication number
AR030957A1
AR030957A1 ARP010104514A ARP010104514A AR030957A1 AR 030957 A1 AR030957 A1 AR 030957A1 AR P010104514 A ARP010104514 A AR P010104514A AR P010104514 A ARP010104514 A AR P010104514A AR 030957 A1 AR030957 A1 AR 030957A1
Authority
AR
Argentina
Prior art keywords
analgesic
composition
glucosamine compositions
glucosamine
efficacy
Prior art date
Application number
ARP010104514A
Other languages
English (en)
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Publication of AR030957A1 publication Critical patent/AR030957A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Una composicion que comprende un material de glucosamina y un compuesto analgésico tal como un fármaco antiinflamatorio no esteroide (AINE) y/o un analgésico opioide y su uso para el tratamiento del dolor en aplicaciones farmacéuticas o veterinarias. Cuando los componentes de la composicion son administrados dentro de ciertas proporciones, la eficacia analgésica de la composicion es superaditiva (sinérgica) con respecto a la eficacia analgésica del compuesto analgésico solo.
ARP010104514A 2000-09-26 2001-09-25 Composiciones de analgesico y glucosamina AR030957A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23540500P 2000-09-26 2000-09-26

Publications (1)

Publication Number Publication Date
AR030957A1 true AR030957A1 (es) 2003-09-03

Family

ID=22885349

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104514A AR030957A1 (es) 2000-09-26 2001-09-25 Composiciones de analgesico y glucosamina

Country Status (6)

Country Link
US (1) US6900189B2 (es)
EP (1) EP1328278A4 (es)
AR (1) AR030957A1 (es)
AU (1) AU2001292929A1 (es)
CA (1) CA2423585A1 (es)
WO (1) WO2002026239A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040241256A1 (en) * 2002-12-05 2004-12-02 Seymour Ehrenpreis Medicinal compositions & therapeutic methods
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
EP1742534A4 (en) * 2004-04-07 2011-04-13 Univ Georgia EXTERNAL GLUCOSAMINE AND GLUCOSAMINE / INFLAMMATORY PRODRUGS, COMPOSITIONS AND METHODS
US8034796B2 (en) 2004-04-07 2011-10-11 The University Of Georgia Research Foundation, Inc. Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
WO2005123130A2 (en) * 2004-06-17 2005-12-29 Osteologix A/S Improved treatments of rheumatic and arthritic diseases comprising combinations of a 5-lipoxygenase inhibitor
US20070248677A1 (en) * 2004-09-17 2007-10-25 Jame Fine Chemicals, Inc. Method for treating warm-blooded vertebrates with a salt of a halide-free glucosamine base and a therapeutic drug
US7662803B2 (en) * 2004-09-17 2010-02-16 Gluconova, LLC Method for treating warm-blooded vertebrates with halide-free glucosamine-acidic drug complexes
US7662802B2 (en) * 2004-09-17 2010-02-16 Gluconova, LLC Halide-free glucosamine-acidic drug complexes
US20070259043A1 (en) * 2004-09-17 2007-11-08 Jame Fine Chemicals, Inc. Halide-free glucosamine-therapeutic drug salt compositions
JP2006290812A (ja) * 2005-04-12 2006-10-26 Rohto Pharmaceut Co Ltd 鎮痛製剤
EP1721602A1 (en) * 2005-05-11 2006-11-15 The Jordanian Pharmaceutical Manufacturing Co. Controlled release oral drug delivery system
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
WO2009002299A1 (en) * 2007-06-22 2008-12-31 Gluconova Llc Method for treating warm-blooded vertebrates with halide-free glucosamine-acidic drug complexes
AR067447A1 (es) * 2008-07-03 2009-10-14 Monte Verde S A Un procedimiento para preparar una composicion farmaceutica que contiene los proincipios activos glucosamina y meloxicam y el uso de dicha asociacion para el tratamiento de patologias degenerativas osteo-articulares
TR201100209A2 (tr) * 2011-01-10 2012-07-23 Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇@ Osteoartrit tedavisi için glukozamin tuzları ve parasetamol içeren farmasötik bileşim.
JP2012051911A (ja) * 2011-10-05 2012-03-15 Rohto Pharmaceutical Co Ltd 鎮痛製剤

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3008874A (en) * 1958-05-15 1961-11-14 Pfizer & Co C Pharmaceutical compositions
ZA828453B (en) * 1981-12-08 1983-12-28 Boots Co Plc Therapeutic agents
US4880921A (en) 1982-05-18 1989-11-14 University Of Florida Brain-specific drug delivery
CH655656B (es) 1982-10-07 1986-05-15
US4647453A (en) 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4571400A (en) 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
US4772591A (en) 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
IT1207994B (it) 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
US4873092A (en) 1987-05-21 1989-10-10 Murata Kikai Kabushiki Kaisha Slow-releasing preparation
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
HUT59692A (en) 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
GB9026005D0 (en) 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
WO1993023055A1 (en) * 1992-05-15 1993-11-25 The University Of British Columbia N-acetyl glucosamine as gastroprotective agent
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5679344A (en) 1995-07-20 1997-10-21 Susan K. Williams Glucosamine composition and method
US5840715A (en) 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US5843919A (en) 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
US5804594A (en) 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US5830432A (en) 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
US5916910A (en) 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
IT1298214B1 (it) * 1998-01-28 1999-12-20 Dompe Spa Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche.
JP2002510336A (ja) * 1998-04-11 2002-04-02 エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ 水溶性ケトプロフェン塩を含有する薬学的調製物及びその使用方法
JP2002516866A (ja) * 1998-06-04 2002-06-11 ニュートラマックス ラボラトリーズ，インコーポレイテッド 結合組織を治療し修復するためのアミノ糖、グリコサミノグリカンおよびｓ−アデノシルメチオニン組成物
US6399093B1 (en) * 1999-05-19 2002-06-04 Advanced Medical Instruments Method and composition to treat musculoskeletal disorders
US6608041B2 (en) * 2000-02-18 2003-08-19 Milton Hammerly Analgesics combined with naturally-occurring chondroprotective agents
US6841544B2 (en) * 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies

Also Published As

Publication number Publication date
US20020058642A1 (en) 2002-05-16
EP1328278A1 (en) 2003-07-23
WO2002026239A1 (en) 2002-04-04
CA2423585A1 (en) 2002-04-04
EP1328278A4 (en) 2004-06-16
AU2001292929A1 (en) 2002-04-08
US6900189B2 (en) 2005-05-31

Similar Documents

Publication Publication Date Title
AR030957A1 (es) Composiciones de analgesico y glucosamina
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
CO5261517A1 (es) Composiciones farmaceuticas analgesicas que contienen buprenorfina/naloxona, buprenorfina/naltrexona o buprenorfina/nalmefen en bajas dosis
AR054064A1 (es) Composicio con ingrediente farmaceutico activo en base a canabinoide para formas de dosis mejoradas
AR049934A1 (es) Nuevo uso de meloxicam en medicina veterinaria
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
WO2001082914A3 (en) Topical anesthetic/opioid formulations and uses thereof
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
BR0107869A (pt) Composições farmacêuticas eletrogiradas
AR040038A1 (es) Composicion analgesica que comprende un agonista alfa-adrenergico con una actividad agonista alfa-2a minima y uso de un agonista alfa-adrenergico y un antagonista selectivo alfa-2a para preparar composiciones farmaceuticas para aliviar el dolor
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
SE0950392L (sv) Sammansättning för behandling av hudåkommor
PE20081072A1 (es) Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales
BRPI0506496B8 (pt) composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ß-ciclodextrina e seu uso no tratamento de êmese composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ß-ciclodextrina e seu uso no tratamento de êmese composição farmacêutica com tolerância melhorada no local de injeção compreendendo sulfobutiléter-ß-ciclodextrina e seu uso no tratamento de êmese
AR044350A1 (es) Manguito y parche analgesico microencapsulado de uso topico para el tratamiento del dolor
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
BRPI0614197B8 (pt) composição farmaceuticamente eficaz em uma forma farmacêutica para administração peroral contendo pelo menos um dos ingredientes ativos indometacina e acemetacina, formas de administração, e, uso da composição
AR045719A1 (es) Formulacion farmaceutica que comprende levotiroxina sodica, celulosa microcristalina y almidon pregelatinizado; uso de la misma para la fabricacion de un medicamento y proceso para preparar dicha formulacion
AR048806A1 (es) Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio
CL2008001477A1 (es) Composicion farmaceutica compuesta por la combinacion sinergica de un agente anticonvulsivante como gabapentina y un agente antiinflamatorio no esteroideo como meloxicam, los rangos de concentracion presentes para la gabapentina son 3 a 300 mg y de 0,1 a 30 mg para meloxicam; y uso para tratar el dolor neuropatico
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
ES2177671T3 (es) Benzamida enterocinetica.
MX9304197A (es) Nuevo uso de dimero de lisozina y composiciones que lo contienen.
DE602004014964D1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel

Legal Events

Date Code Title Description
FB Suspension of granting procedure